DS
TBIO

David Shaw’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

David Shaw’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,195
Closed -$66K – 5218
2022
Q3 		$66K Buy
+2,195
New +$77.3K ﹤0.01% 4653
2021
Q4 		– Sell
-1,108
Closed -$222K – 5788
2021
Q3 		$222K Buy
+1,108
New +$281K ﹤0.01% 4518

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

David Shaw's TBIO Position: Q4 2022 in Review

David Shaw sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q4 2022, closing a stake of 2,195 shares — an estimated $66K sold.

David Shaw first reported a position in TBIO in Q3 2021 and held it in 2 quarters. The position peaked at $222K in Q3 2021. 24 funds tracked by Wall St. Rank hold TBIO as of Q4 2022.

  • David Shaw reported no remaining Telesis Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • David Shaw sold 2,195 Telesis Bio, Inc. Common Stock shares in Q4 2022, an estimated $66K.
  • David Shaw first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • David Shaw's Telesis Bio, Inc. Common Stock position peaked at $222K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.